Filed 3.5y ago· Dec 19, 2022
560 days to disclose · 515 past 45-day window
Thomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+21.2% vs S&P 500
Trade dateJun 7, 2021
2000084729 Bristol-Myers Squibb Company
⚑ Pharmaceutical
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY 2000084729 Bristol-Myers Squibb Company ⚑ Pharmaceutical · Ways and Means | Jun 7, 2021 560 days to disclose · 515 past 45-day window | Flat·+0.0% +21.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY 2000084726 Bristol-Myers Squibb Company ⚑ Pharmaceutical · Ways and Means | Jun 4, 2021 563 days to disclose · 518 past 45-day window | Flat·+0.0% +21.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jul 30, 2020 872 days to disclose · 827 past 45-day window | price pending | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jul 10, 2020 892 days to disclose · 847 past 45-day window | price pending | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY 2000084548 Bristol-Myers Squibb Company ⚑ Pharmaceutical · Ways and Means | Jan 9, 2020 1075 days to disclose · 1030 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Johnson & Johnson JNJ 2000084479 Johnson & Johnson ⚑ Pharmaceutical · Ways and Means | Jan 1, 2020 1083 days to disclose · 1038 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Ways and Means | Oct 17, 2019 1159 days to disclose · 1114 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Regeneron Pharmaceuticals REGN ⚑ Pharmaceutical · Ways and Means | Aug 21, 2019 1216 days to disclose · 1171 past 45-day window | price pending | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY 2000084402 Bristol-Myers Squibb Company ⚑ Pharmaceutical · Ways and Means | Apr 8, 2019 1351 days to disclose · 1306 past 45-day window | price pending | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Mar 29, 2019 1361 days to disclose · 1316 past 45-day window | price pending | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Apr 17, 2018 1707 days to disclose · 1662 past 45-day window | price pending | $1K-$15K midpoint $8K |
Nov 5, 2021 4.6y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Jazz Pharmaceuticals JAZZ Ordinary Shares ⚑ Pharmaceutical · Ways and Means | Oct 19, 2021 17 days to disclose | Good buy·+$4.5K+56.7% +41.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 5, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Crispr Therapeutics Ag CRSP Common Shares ⚑ Pharmaceutical · Ways and Means | Sep 20, 2021 15 days to disclose | Flat·+0.0% +13.1% vs S&P 500 | $50K-$100K midpoint $75K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jun 7, 2021 108 days to disclose · 63 past 45-day window | Flat·+0.0% +21.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jun 4, 2021 111 days to disclose · 66 past 45-day window | Flat·+0.0% +21.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Crispr Therapeutics Ag CRSP Common Shares ⚑ Pharmaceutical · Ways and Means | Jun 3, 2021 112 days to disclose · 67 past 45-day window | Bad buy·−$38.6K-51.4% −73.5% vs S&P 500 | $50K-$100K midpoint $75K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Ways and Means | May 5, 2021 141 days to disclose · 96 past 45-day window | Flat·+0.0% +71.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | AstraZeneca AZN Depositary Shares ⚑ Pharmaceutical · Ways and Means | Feb 24, 2020 577 days to disclose · 532 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jan 9, 2020 623 days to disclose · 578 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jan 9, 2020 623 days to disclose · 578 past 45-day window | price pending | $50K-$100K midpoint $75K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | AstraZeneca AZN Depositary Shares ⚑ Pharmaceutical · Ways and Means | Jan 7, 2020 625 days to disclose · 580 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Ways and Means | Nov 18, 2019 675 days to disclose · 630 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Ways and Means | Nov 18, 2019 675 days to disclose · 630 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Ways and Means | Nov 12, 2019 681 days to disclose · 636 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Catalent, Inc CTLT Catalent ⚑ Pharmaceutical · Ways and Means | Jun 18, 2019 828 days to disclose · 783 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Apr 8, 2019 899 days to disclose · 854 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Pfizer PFE ⚑ Pharmaceutical · Ways and Means | Apr 8, 2019 899 days to disclose · 854 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Oct 1, 2018 1088 days to disclose · 1043 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 6, 2017 1387 days to disclose · 1342 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Merck MRK Stock ⚑ Pharmaceutical · Ways and Means | Aug 17, 2017 1498 days to disclose · 1453 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Ways and Means | Aug 17, 2017 1498 days to disclose · 1453 past 45-day window | price pending | $1K-$15K midpoint $8K |